Home > Boards > US Listed > Alternative Energy > Adventure Gold Inc. (AGE)

From www.Illumina.com... “The massively parallel sequencing technology known as

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
thefamilyman Member Profile
 
Followed By 25
Posts 2,602
Boards Moderated 0
Alias Born 06/05/12
160x600 placeholder
AgeX Therapeutics to Present at Metabesity 2019 Business Wire - 10/11/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:30:55 AM
Industry Leaders Aubrey De Grey And Frank Jaksch Join Yuva Biosciences Advisory Board PR Newswire (US) - 9/10/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2019 7:01:12 AM
AgeX Therapeutics Presents at the Rodman & Renshaw Global Investment Conference Business Wire - 9/9/2019 7:00:00 AM
AgeX Therapeutics Publishes Theoretical Basis of Human Cell Age-Reversal in the Journal Regenerative Medicine Business Wire - 9/4/2019 8:00:00 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 8/16/2019 4:02:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/15/2019 2:51:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2019 5:30:34 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 5:17:09 PM
AgeX Therapeutics, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update Business Wire - 8/14/2019 5:16:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2019 5:17:45 PM
Regenerative Medicine Leader Michael H. May Joins AgeX Board of Directors Business Wire - 8/5/2019 5:14:00 PM
AgeX Therapeutics’ CEO Dr. Michael D. West to Present at Ending Age-Related Diseases: Investment Prospects & Advances in Re... Business Wire - 7/9/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:54:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 4:44:52 PM
AgeX Therapeutics Reports First Quarter 2019 Financial Results and Provides Business Update Business Wire - 5/15/2019 4:05:00 PM
AgeX Therapeutics to Participate at Biotech Investing in Longevity from Aikora Health and Foresight Institute Business Wire - 5/1/2019 8:00:00 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 4:47:46 PM
AgeX Therapeutics to Present at Master Investor Show 2019 Business Wire - 4/5/2019 8:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 5:24:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2019 5:05:13 PM
AgeX Therapeutics Reports Fourth Quarter and Annual 2018 Financial Results and Provides Business Update Business Wire - 4/1/2019 4:48:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/27/2019 4:58:49 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/26/2019 3:25:53 PM
thefamilyman   Thursday, 01/10/19 04:39:25 PM
Re: thefamilyman post# 16
Post # of 44 
From www.Illumina.com...

“The massively parallel sequencing technology known as next-generation sequencing (NGS) has revolutionized the biological sciences. With its ultra-high throughput, scalability, and speed, NGS enables researchers to perform a wide variety of applications and study biological systems at a level never before possible.

Today's complex genomic research questions demand a depth of information beyond the capacity of traditional DNA sequencing technologies. Next-generation sequencing has filled that gap and become an everyday research tool to address these questions.”



"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist